| Literature DB >> 35089052 |
Eoghan Casey1,2, Brian McDonnell1, Kelsey White1,2, Panagiota Stamou2,3, Tadhg Crowley2,3, Ian O'Neill1,2, Katherine Lavelle1,2, Stephen Hayes1, Gabriele A Lugli4, Silvia Arboleya5, Kieran James2, Marco Ventura4, Ines Martinez6, Miguel Gueimonde5, Fabio Dal Bello6, Ken Nally2,3, Jennifer Mahony1,2, Douwe van Sinderen1,2.
Abstract
The field of metagenomics has rapidly expanded to become the go-to method for complex microbial community analyses. However, there is currently no straightforward route from metagenomics to traditional culture-based methods of strain isolation, particularly in (bacterio)phage biology, leading to an investigative bottleneck. Here, we describe a method that exploits specific phage receptor binding protein (RBP)-host cell surface receptor interaction enabling isolation of phage-host combinations from an environmental sample. The method was successfully applied to two complex sample types-a dairy-derived whey sample and an infant fecal sample, enabling retrieval of specific and culturable phage hosts. IMPORTANCE PhRACS aims to bridge the current divide between in silico genetic analyses (i.e., phageomic studies) and traditional culture-based methodology. Through the labeling of specific bacterial hosts with fluorescently tagged recombinant phage receptor binding proteins and the isolation of tagged cells using flow cytometry, PhRACS allows the full potential of phageomic data to be realized in the wet laboratory.Entities:
Keywords: RBP; cytometry; fecal; fluorescence; fluorescent; metagenome; phageome; virome; whey
Year: 2022 PMID: 35089052 PMCID: PMC8725590 DOI: 10.1128/mbio.03334-21
Source DB: PubMed Journal: mBio Impact factor: 7.867
FIG 1PhRACS workflow. Virome analysis is first performed on a complex sample, and putative RBP nucleotide sequences are identified. RBP-encoding genes are then cloned on a suitable plasmid and expressed. Incubation of GFP-tagged RBPs with the processed sample then allows isolation of the phage host from the complex sample by FACS.
Bacterial strains and plasmids used in this study
| Bacterial strain or plasmid | Relevant characteristic(s) | Reference |
|---|---|---|
| Bacterial strains | ||
| | ||
| NZ9000 | MG1363 containing |
|
| 3107 | Host for TP901-1 |
|
| UC509.9 | Host for Tuc2009 |
|
| SC34 | Host for BB4_2 | This study |
| | ||
| LMDS5 | Host for LMD_1_2 | This study |
| | ||
| BL21 (DE3) | Protein expression strain | New England Biolabs |
| Undefined starter culture | ||
| MUO12 | This study | |
| Plasmids | ||
| pNZ8048 | Standard |
|
| pGFP8048 | pNZ8048 derivative harboring GFP, contains a His tag cloned in frame | This study |
| pNZ44 | Standard |
|
| pNZ8048-His-GFP-UALTuc2009 | pNZ8048 encoding Tuc2009 | This study |
| pNZ8048-His-GFP-ULTP901-1 | pNZ8048 encoding TP901-1 | This study |
| pGFP8048-His-GFP-RBPLMD | pGFP8048 encoding ΦLMD_1_2 | This study |
| pHTP9-423phi1Rv1 | pHTP9 encoding 423phi1Rv1 conformation | This study |
| pHTP9-RBPBB4_2 | pHTP9 encoding BB4_2 | This study |
Oligonucleotides used in this study
| Oligonucleotide | Sequence (5′-3′) | Comment | Restriction enzyme |
|---|---|---|---|
| GFPFwHis |
| F primer of gfp+ flanked by a His tag | SphI |
| GFPRevlinkBppU |
| R primer of gfp+ flanked by a linker and region complementary to BppU N terminus | |
| BppUF |
| F primer BppL Tuc2009/TP901-1 | |
| BppLTucR |
| R primer of BppL Tuc2009 | SpeI |
| BppLTPR |
| R primer of BppL TP901-1 | SpeI |
| GFP8048F |
| F primer of gfp+ flnked by a His tag | SphI |
| GFP8048R |
| R primer of gfp+ flanked by flexible linker with MCS (EcoRI, EcoRV, KpnI, SpeI, XbaI) | SpeI |
| LMD_22F |
| F primer LMD_1_22 | EcoRI |
| LMD_22R |
| R primer LMD_1_22 | KpnI |
| GFP423phi1F |
| F primer targeting 423phi1_Rv1 flanked by pHTP9-specific overhang | NA |
| GFP423phi1R |
| R primer targeting 423phi1_Rv1 flanked by pHTP9-specific overhang | NA |
| BB4-RBPF |
| F primer BB4_2_04 flanked by pHTP9-specific overhang | NA |
| BB4-RBPR |
| R primer BB4_2_04 flanked by pHTP9-specific overhang | NA |
Restriction sites are underlined. Linker and overhang sequences are italicized. His tag sequences are indicated in boldface type.
MCS, multiple cloning sites.
NA, not available.
FIG 2(A1) Interaction between recombinant HisGFP-UAL2009 and Tuc2009 host L. cremoris UC509.9. (A2) Interaction between recombinant HisGFP-UAL2009 and Tuc2009 nonhost L. cremoris 3107. (B1) Interaction between recombinant HisGFP-ULTP901 and TP901-1 nonhost L. cremoris UC509.9. (B2) Interaction between recombinant HisGFP-ULTP901 and TP901-1 host L. cremoris 3107.
FIG 3(A) HHpred analysis of orf22LMD_1_2, a putative RBP, displaying similarity to lactococcal phages 1358 and p2 RBPs. (B) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of HisGFP-RBPLMD fusion protein (indicated by the red arrow). (C) Putative phage-susceptible hosts within an undefined culture specifically labeled by putative GFP-tagged putative RBPs (C1 to C3), visualized using fluorescence microscopy. Protein buffer (C4 to C6) was employed as a control. DIC, differential interference contrast.
FIG 4(A) Dot plot analysis of undefined culture MUO12 labeled with protein buffer (PB) (A1) and HisGFP-RBPLMD (A2). SSC, side scatter. (B) Proportion of GFP-positive events expressed as a percentage of total events processed. (C) Number of events sorted using gating strategy targeting GFP-positive cells evident in Fig. 4, panel A2. (D) Plate counts of colony morphologies evident in sorted population following plating on MRS agar. (E) Assessment of HisGFP-RBPLMD binding to Ln. mesenteroides (E1 to E3) and L. lactis subsp. lactis (E4 to E6) FACS coisolates. Colonies were visualized using fluorescence confocal microscopy at a wavelength of 488 nm (E2 and E4) overlaid on differential interference contrast (DIC) microscopy (E1 and E3). (F) Confirmation of recovery of Ln. mesenteroides phage LMD_1_2 host by spot assay using original whey sample MUO12, where visible zones of lysis indicate successful infection (F1 to F9).
Microbial composition (greater than or equal to 0.01% read abundance) in fecal sample T60III by phylum, family, genus, and Bifidobacterium species
| Analysis | Level | Taxon | Abundance (%) |
|---|---|---|---|
| 16S | Phylum |
| 18.78 |
|
| 7.89 | ||
|
| 2.26 | ||
|
| 71.05 | ||
| 16S | Family |
| 18.72 |
|
| 6.36 | ||
|
| 1.52 | ||
|
| 71.00 | ||
| 16S | Genus |
| 6.36 |
|
| 1.52 | ||
|
| 70.48 | ||
|
| 18.72 | ||
| ITS | 60.45 | ||
| 38.51 | |||
| 0.89 | |||
| 0.05 | |||
| 0.02 | |||
| 0.02 | |||
| 0.01 | |||
| 0.01 | |||
| 0.01 | |||
| 0.01 | |||
| 0.01 | |||
| Other | 0.02 |
FIG 5(A) Dot plot analysis of the T60III bifidobacterial community labeled with PB (A1) and HisGFP-Rv1423phi1 (A2). (B) Proportion of GFP-positive events expressed as a percentage of total events processed. (C) Number of events sorted using gating strategy targeting GFP-positive cells evident in Fig. 4, panel A. (D) Plate counts (on MRS agar) of populations exhibiting distinct colony morphologies present in sorted population. (E) Confirmation of recovery of potential host by GFP-RBP labeling of B. pseudocatenulatum cultures derived from isolated colonies (E1 to E9). Unlabeled coisolates (B. longum subsp. longum) are shown in E10 to E18.